---
title: BioAscent Discovery vs TRiCBIO
slug_a: bioascent-discovery
slug_b: tricbio
site: cro
review_signal_gate: closed
canonical_path: /compare/bioascent-discovery/tricbio
---

# BioAscent Discovery vs TRiCBIO

Side-by-side profile data from each company listing on this directory.

## BioAscent Discovery

- Profile: [/companies/bioascent-discovery](/companies/bioascent-discovery)

BioAscent Discovery — BioAscent is an integrated drug discovery CRO offering medicinal and synthetic chemistry, computational chemistry, biochemical and biophysical assay development, high-throughput screening, DMPK, flow cytometry, and compound management services to biotech and pharma clients globally.

Services: 8. Modalities: 0. Indications: 2. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Flow Cytometry Services

### Modalities

- Data not yet provided.

### Indications

- Immunology
- Neurology

### Phases

- Discovery

### Sourcing models

- Data not yet provided.

## TRiCBIO

- Profile: [/companies/tricbio](/companies/tricbio)

TRiCBIO — TRiCBIO provides human organoid research services for efficacy, safety, mechanism and immune-context studies using PDO 2.0 and ALI platforms, supporting biopharma and CRO teams in candidate evaluation and translational research.

Services: 8. Modalities: 3. Indications: 4. Locations: 3. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Discovery Research
- Target Identification & Validation
- Medicinal Chemistry
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Biomarker Assays
- Flow Cytometry Services
- Translational Research

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)

### Indications

- Oncology
- Immunology
- Rare Disease
- Gastroenterology

### Phases

- Discovery
- Preclinical (General)

### Sourcing models

- Full-Service Outsourcing (FSO)